Syndax Pharmaceuticals News

Syndax Pharmaceuticals | DEF 14A: Definitive information statements

Apr 2 16:18 ET

Syndax Pharmaceuticals | DEFA14A: Others

Apr 2 16:05 ET

Syndax Pharmaceuticals | 8-K: Current report

Mar 18 07:14 ET

Syndax Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 27 17:32 ET

Syndax Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 17:28 ET

Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update

Feb 27 16:09 ET

Syndax Pharmaceuticals | 8-K: Current report

Dec 20, 2023 08:40 ET

Syndax Pharmaceuticals | 8-K: Current report

Dec 15, 2023 17:29 ET

Syndax Pharmaceuticals | 8-K: Current report

Dec 12, 2023 16:05 ET

Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update

Nov 2, 2023 16:03 ET

Syndax Pharmaceuticals | 8-K: Current report

Oct 2, 2023 07:04 ET

Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update

Aug 3, 2023 16:04 ET

Syndax Pharmaceuticals | 8-K: Current report

Jul 24, 2023 07:07 ET

Syndax Pharmaceuticals | 8-K: Current report

May 26, 2023 16:47 ET

Syndax Pharmaceuticals | 8-K: Current report

May 17, 2023 18:01 ET

Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update

May 8, 2023 16:07 ET

Syndax Pharmaceuticals | DEFA14A: Others

Apr 18, 2023 16:00 ET

Syndax Pharmaceuticals | DEFA14A: Others

Apr 7, 2023 16:02 ET

Syndax Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 7, 2023 16:00 ET

Syndax Pharmaceuticals | 8-K: Current report

Mar 30, 2023 08:00 ET